Training is crucial for supporting GMP operations in commercial-scale bioprocessing.
The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.
High-cost-per-dose large molecules can make a big impact on cell and gene therapy supply chain management.
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
When it comes to immediate-release tablet formulations, the choice of disintegrant can have a significant effect on the rate and extent of drug dissolution.
Dr Rupa Pike, Sr. Director & Global Head Strategic Alliances and Field Scientists for Cell Therapy, Catalent, shares insight on de-risking cell therapy programs using streamlined development and manufacturing platforms.
Analytical methods need a boost to ensure quality control for cell and gene therapies.
The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX for improved dissolution in immediate-release tablet formulations.
David McErlane, Group President of Biologics, Catalent, reacts to trends in cell and gene therapy development and manufacturing and comments on Catalent's ESG strategy to support people, the environment, and communities.
Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.
Many biologic drug manufacturers encounter similiar challenges; precompetitive collaboration can help resolve these issues. Representatives of the IQ Consortium’s Biologics CMC Leadership Group describe efforts to address the safe handling of biologic drugs in closed-system transfer devices in healthcare settings and the need for phase-appropriate specifications.
Modified-release dosage forms present new opportunities for drug developers and can help overcome challenges, such as short biological half-life or poor bioavailability due to degradation in the stomach.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
A statistical analysis for determining an expiration date can be applied to replicates or their corresponding averages as suggested in industry guidelines.
Life sciences data sets can be vast and complex to process, but up to now bringing intelligent automation systems up to speed and validating them has felt debilitatingly onerous. Large language models tackle these barriers head on. Ramesh Ramani and RaviKanth Valigari, technology innovators at ArisGlobal, explain.
Getting IT, engineering, and manufacturing on the same page requires a delicate balance.
The purpose of this article was to demonstrate the application of a new thermogelling matrix in the healing of wounds.
Using new co-processing technologies, the authors show that it is possible to formulate an 'all-round' excipient.
More than a third of CMOs are struggling to keep skilled technical and production staff.
This paper reviews considerations for the formulation of chewable tablets including sensory characteristics, chewability assessment, and drug release.
The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.
The complexity of the RNA production process creates challenges.
The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.
Training is crucial for supporting GMP operations in commercial-scale bioprocessing.
The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.
Discover why integrating Human Factors and patient activities from early device to manufacturing is essential to develop a patient-centric inhaler.
The authors propose an alternative to the USP disintegration test method. The method embraces physiological conditions of the oral cavity, as a screening tool for developing ODT products.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
The deadline for stakeholder consultation submissions on the new and updated regulations is Oct. 7, 2025.